Ann: XTEK confirms delivery of 2nd tranche of US$33.2m order, page-8

Little Eagle, Thanks for posting that Eureka Report interview between Alan Kohler and our CEO. I have just read it and it was a real eye opener.

I extrapolated his figures for production and costs and it works out their Ohio plant is producing A$1million per day in product which is already sold, 5 days per week and with a full order book till at least the end of September. Gross profit margins vary between 35 and 60%. Using an average 40% that means A$26million EBITDA for the current quarter alone! And that does not take into account any contribution from Australia and their Adelaide plant.

Compare this with their current market cap of A$39million and it is easy to conclude that XTE at current prices is an absolute bargain, shortly to be in a position to commence big returns to patient shareholders, and due for a major re-rating by the market.